Health Policy of COVID-19 management

Prof. Chen Wang (Beijing, China)

Source: ERS Webinar 2020: Health Policy of COVID-19 management

Number: 0

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Prof. Chen Wang (Beijing, China). Health Policy of COVID-19 management. ERS Webinar 2020: Health Policy of COVID-19 management

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

Khalid Hassan Ba-Msahell - 08.04.2020 09:37
Very nice lecture

You must Login to comment this presentation.

Related content which might interest you:

SARS-CoV-2 (COVID-19): Research response Source: Webinar 2020: SARS-CoV-2 (COVID-19): research response Year: 2020
Diagnosis and treatment of COVID-19 Source: Webinar 2020: Diagnosis and treatment of COVID-19 Year: 2020
COVID-19: Q and A Source: ERS Webinar 2020: COVID-19: Q and A Year: 2020
ERS/ATS joint webinar on rehabilitation after COVID 19 disease: Q&A on Programme Source: ERS webinar 2020: ERS/ATS joint webinar on rehabilitation after COVID 19 disease: Q&A on Programme Year: 2020
ERS/ATS joint webinar: Rehabilitation after COVID 19 disease Source: ERS webinar 2020: ERS/ATS joint webinar: Rehabilitation after COVID 19 disease Year: 2020
ERS/ATS joint webinar on rehabilitation after COVID 19 disease: Q&A on Assessment Source: ERS webinar 2020: ERS/ATS joint webinar on rehabilitation after COVID 19 disease: Q&A on Assessment Year: 2020
Perspectives of the management of COVID-19 infection in China Source: Webinar 2020: Perspectives of the management of COVID-19 infection in China Year: 2020
Interview on Coronavirus COVID-19 management experience in China Source: Webinar 2020: Interview on Coronavirus COVID-19 management experience in China Year: 2020
Cross-boarder surveillance of enterovirus-D68 in Europe during the 2014 North-American outbreak Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015
Late-breaking abstract: Prevalence of influenza A H1N1 virus infection in patients with asthmatic crisis of the National Institute of Respiratory Diseases (in Mexico City) Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections Year: 2011
Pandemic influenza A H1N1 in Argentina: Statistics from the epidemiological surveillance system Source: Annual Congress 2010 - Influenza A (H1N1): epidemiology Year: 2010
Coronavirus disease: outbreak in China and globally Source: Webinar 2020 Year: 2020
The comaprison of clinical characteristics and courses of pediatric patients hospitalized with pandemic influenza A (H1N1) and seasonal influenza in Korea from 2009-2011 Source: International Congress 2014 – Prevention, diagnosis and consequences of respiratory infections in children Year: 2014
Medical staff attitude to vaccination against an influenza virus Source: Annual Congress 2013 –Epidemiology of respiratory disease Year: 2013
Clinical and epidemiological assessment of the regional program of vaccination for pneumococcal infections Source: International Congress 2016 – Monitoring comorbidities Year: 2016
Impact and management of TB childhood outbreaks in EU/EEA Source: Annual Congress 2013 –Epidemiological and public health features of tuberculosis Year: 2013
A nosocomial outbreak of influenza during a period without influenza epidemic activity Source: Eur Respir J 2003; 21: 303-307 Year: 2003
Lives on the line? Ethics and practicalities of duty of care in pandemics and disasters Source: Eur Respir J 2009; 33: 303-309 Year: 2009
Rapid spread of the novel respiratory syncytial virus A ON1 genotype, during the epidemic seasons 2011-2013 Source: International Congress 2014 – Virus-triggered lower respiratory disease in children Year: 2014
TB among prisoners in Romania, 2009-2011 Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III Year: 2013